부산대학교 도서관

Morrell, B.; Otsu, K.; Agha, A.; Fan, D.D.; Kim, S.; Ginting, M.F.; Lei, X.; Edlund, J.; Fakoorian, S.; Bouman, A.; Chavez, F.; Kim, T.; Correa, G.J.; Saboia, M.; Santamaria-Navarro, A.; Lopez, B.; Kim, B.; Jung, C.; Sobue, M.; Peltzer, O.C.; Ott, J.; Trybula, R.; Touma, T.; Kaufmann, M.; Vaquero, T.S.; Pailevanian, T.; Palieri, M.; Chang, Y.; Reinke, A.; Anderson, M.; Scholler, F.E.T.; Spieler, P.; Clark, L.M.; Archanian, A.; Chen, K.; Melikyan, H.; Dixit, A.; Delecki, H.; Pastor, D.; Ridge, B.; Marchal, N.; Uribe, J.; Dey, S.; Ebadi, K.; Coble, K.; Dimopoulos, A.N.; Thangavelu, V.; Varadharajan, V.S.; Palomo, N.; Rosinol, A.; Chatterjee, A.; Kanellakis, C.; Lindqvist, B.; Corah, M.; Strickland, K.; Stonebraker, R.; Milano, M.; Denniston, C.E.; Sahnoune, S.; Claudet, T.; Lee, S.; Salhotra, G.; Terry, E.; Musuku, R.; Schmid, R.; Tran, T.; Kourchians, A.; Schachter, J.; Azpurua, H.; Resende, L.; Kalantari, A.; Nash, J.; Lee, J.; Patterson, C.; Blank, J.G.; Patath, K.; Kubo, Y.; Alimo, R.; Almalioglu, Y.; Curtis, A.; Sly, J.; Wells, T.; Ho, N.T.; Kochenderfer, M.; Beltrame, G.; Nikolakopoulos, G.; Shim, D.; Carlone, L.; Burdick, A.J.

IEEE Transactions on Field Robotics IEEE Trans. Field Robot. Field Robotics, IEEE Transactions on. 1:476-526 2024

Chalatsi T; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Wosnitzka E; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Kolaxi A; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Fernandez LMJ; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Scholler J; Wyss Center, Geneva, Switzerland.; Batti L; Wyss Center, Geneva, Switzerland.; Restivo L; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Knott G; EPFL, Bioelectron Microscopy Core Facility, Lausanne, Switzerland.; Lüthi A; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Mameli M; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.; Nikoletopoulou V; Department of Fundamental Neurosciences, University of Lausanne, Lausanne, Switzerland.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101265188 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8635 (Electronic) Linking ISSN: 15548627 NLM ISO Abbreviation: Autophagy Subsets: MEDLINE

Schipani, P.; Campana, S.; Claudi, R.; Aliverti, M.; Baruffolo, A.; Ben-Ami, S.; Biondi, F.; Capasso, G.; Cosentino, R.; D'Alessio, F.; D'Avanzo, P.; Hershko, O.; Kuncarayakti, H.; Landoni, M.; Munari, M.; Pignata, G.; Rubin, A.; Scuderi, S.; Vitali, F.; Young, D.; Achren, J.; Araiza-Duran, J. A.; Arcavi, I.; Brucalassi, A.; Bruch, R.; Cappellaro, E.; Colapietro, M.; Della Valle, M.; De Pascale, M.; Di Benedetto, R.; D'Orsi, S.; Gal-Yam, A.; Genoni, M.; Hernandez, M.; Kotilainen, J.; Causi, G. Li; Marty, L.; Mattila, S.; Radhakrishnan, K.; Rappaport, M.; Ricci, D.; Riva, M.; Salasnich, B.; Savarese, S.; Smartt, S.; Sanchez, R. Zanmar; Stritzinger, M.; Ventura, H.; Pasquini, L.; Scholler, M.; Kaufl, H. U.; Accardo, M.; Mehrgan, L.; Pompei, E.

Aghajanian, H.; Frantz, A.M.; Riener, R.; Wang, A.; Bao, Y.; Zhang, Y.; Matsuda, D.; Li, J.J.; Chu, D.; Hunter, T.L.; Soldevila-Casals, F.; Yong, Q.; Nguyen, M.; Sievers, S.A.; Nguyen, D.P.; Roberts, S.; Galvan, D.; Vega, J.; Butcher, M.; Zhang, S.; Flynn, S.; Kuo, Y.; Tanis, S.P.; Scholler, J.; Adams, G.B.; Rosenzweig, M.; Karmali, P.; June, C.; Bot, A.I.

Cytotherapy. 27(5):S161-S161

Golinelli G; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children and Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.; Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Roussel-Gervais A; Antion Biosciences SA, Geneva, Switzerland.; Šakić A; Antion Biosciences SA, Geneva, Switzerland.; Ilmjärv S; Antion Biosciences SA, Geneva, Switzerland.; Song D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Gabunia K; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Ji M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Fan TJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Gupta A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Deshmukh M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Berjis A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA, United States.; Cuoghi Costantini R; Unit of Clinical Statistics, University Hospital of Modena, Modena, Italy.; Apodaca K; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Sheppard NC; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Kili S; Antion Biosciences SA, Geneva, Switzerland.; Dominici M; Laboratory of Cellular Therapy, Division of Oncology, Department of Medical and Surgical Sciences for Children and Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.; Alessandrini M; Antion Biosciences SA, Geneva, Switzerland.; June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Parker Institute for Cancer Immunotherapy at University of Pennsylvania, University of Pennsylvania, Philadelphia, PA, United States.; Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Ho M; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Paruzzo L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Noll JH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Stella F; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Devi P; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Ndeupen S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Day YA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Chen GM; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Cohen IJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Ramirez-Fernandez A; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Waxman A; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Kapur S; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Chen F; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Xu R; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Huff A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Jarocha D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Patel V; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Bochi-Layec AC; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Ramasubramanian R; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Liu S; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Bouvier R; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; de Souza VB; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Patel H; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Li Z; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Carturan A; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Michener P; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Hopkins CR; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Koucky O; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Minehart J; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Dimitri A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Nabar NR; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Hasanali ZS; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Ciccarelli BT; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Hung P; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Williams E; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Bartoszek R; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lavorando M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Mohan S; Department of Radiology, Division of Neuroradiology, University of Pennsylvania, Philadelphia, PA, USA.; Gonzalez VE; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Porazzi P; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Bhoj VG; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Apostolidis SA; Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, USA.; Vogl DT; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Porter DL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Diorio C; Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.; Roche AM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Everett JK; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Bushman FD; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Nathanson KL; Division of Translational Medicine and Human Genetics, University of Pennsylvania, Philadelphia, PA, USA.; Stadtmauer EA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Susanibar-Adaniya SP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Garfall AL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Ruella M; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, USA. mruella@upenn.edu.; Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. mruella@upenn.edu.; Cohen AD; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. adam.cohen@pennmedicine.upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. adam.cohen@pennmedicine.upenn.edu.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. adam.cohen@pennmedicine.upenn.edu.; Fraietta JA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Center for Cell Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Hunter TL; Capstan Therapeutics, San Diego, CA, USA.; Bao Y; Capstan Therapeutics, San Diego, CA, USA.; Zhang Y; Capstan Therapeutics, San Diego, CA, USA.; Matsuda D; Capstan Therapeutics, San Diego, CA, USA.; Riener R; Capstan Therapeutics, San Diego, CA, USA.; Wang A; Capstan Therapeutics, San Diego, CA, USA.; Li JJ; Capstan Therapeutics, San Diego, CA, USA.; Soldevila F; Capstan Therapeutics, San Diego, CA, USA.; Chu DSH; Capstan Therapeutics, San Diego, CA, USA.; Nguyen DP; Capstan Therapeutics, San Diego, CA, USA.; Yong QC; Capstan Therapeutics, San Diego, CA, USA.; Ross B; Capstan Therapeutics, San Diego, CA, USA.; Nguyen M; Capstan Therapeutics, San Diego, CA, USA.; Vestal J; Capstan Therapeutics, San Diego, CA, USA.; Roberts S; Capstan Therapeutics, San Diego, CA, USA.; Galvan D; Capstan Therapeutics, San Diego, CA, USA.; Vega JB; Capstan Therapeutics, San Diego, CA, USA.; Jhung D; Capstan Therapeutics, San Diego, CA, USA.; Butcher M; Capstan Therapeutics, San Diego, CA, USA.; Nguyen J; Capstan Therapeutics, San Diego, CA, USA.; Zhang S; Capstan Therapeutics, San Diego, CA, USA.; Fernandez C; Capstan Therapeutics, San Diego, CA, USA.; Chen J; Capstan Therapeutics, San Diego, CA, USA.; Herrera C; Capstan Therapeutics, San Diego, CA, USA.; Kuo Y; Capstan Therapeutics, San Diego, CA, USA.; Pica EM; Capstan Therapeutics, San Diego, CA, USA.; Mondal G; Capstan Therapeutics, San Diego, CA, USA.; Mammen AL; Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.; Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Tanis SP; Capstan Therapeutics, San Diego, CA, USA.; Sievers SA; Capstan Therapeutics, San Diego, CA, USA.; Frantz AM; Capstan Therapeutics, San Diego, CA, USA.; Adams GB; Capstan Therapeutics, San Diego, CA, USA.; Shawver L; Capstan Therapeutics, San Diego, CA, USA.; Farzaneh-Far R; Capstan Therapeutics, San Diego, CA, USA.; Rosenzweig M; Capstan Therapeutics, San Diego, CA, USA.; Karmali PP; Capstan Therapeutics, San Diego, CA, USA.; Bot AI; Capstan Therapeutics, San Diego, CA, USA.; June CH; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, PA, USA.; Aghajanian H; Capstan Therapeutics, San Diego, CA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Planchette A; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Gantar I; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Scholler J; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Sobolewski A; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Cabara Y; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Wojcicki K; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Brana C; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Durand T; Nantes Université, CHU Nantes, INSERM, TENS, The Enteric Nervous System in Gut and Brain Diseases, IMAD, Nantes, France.; Naveilhan P; Nantes Université, CHU Nantes, INSERM, TENS, The Enteric Nervous System in Gut and Brain Diseases, IMAD, Nantes, France.; Barthet G; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Neunlist M; Nantes Université, CHU Nantes, INSERM, TENS, The Enteric Nervous System in Gut and Brain Diseases, IMAD, Nantes, France.; Pagès S; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland.; Gora MJ; Wyss Center for Bio and Neuroengineering, Geneva, Switzerland. michalina.gora@wysscenter.ch.

Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE

Morel, T.; Castro, N.; Fossati, L.; Hubrig, S.; Langer, N.; Przybilla, N.; Scholler, M.; Carroll, T.; Ilyin, I.; Irrgang, A.; Oskinova, L.; Schneider, F. R. N.; Diaz, S. Simon; Briquet, M.; Gonzalez, J. F.; Kharchenko, N.; Nieva, M. -F.; Scholz, R. -D.; de Koter, A.; Hamann, W. -R.; Herrero, A.; Apellaniz, J. Maiz; Sana, H.; Arlt, R.; Barba, R.; Dufton, P.; Kholtygin, A.; Mathys, G.; Piskunov, A.; Reisenegger, A.; Spruit, H.; Yoon, S. -C.

Mai, D.; Johnson, O.; Fan, T.; Reff, J.; Boyce, T.; Mehta, A.; Scholler, J.; Sheppard, N.; June, C.

Cytotherapy. 25(6):S236-S237

Ramírez-Fernández Á; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. angel.ramirez-fernandez@pennmedicine.upenn.edu.; Dimitri AJ; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Chen F; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Bartoszek R; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Chen GM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Córdoba-Espejo L; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Zhou Y; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Tang YH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lin CT; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Acosta R; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Ghilardi G; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Porazzi P; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Pellicer M; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Profitós-Pelejà N; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Chew A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Jadlowsky JK; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Gonzalez VE; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Siegel DL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Roué G; Lymphoma Translational Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Ruella M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Lotze MT; Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA.; Riley JL; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Fraietta JA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA, USA. jfrai@upenn.edu.

Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE

Patel RP; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Ghilardi G; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Zhang Y; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Chiang YH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, MacKay Memorial Hospital, Taipei, Taiwan.; Xie W; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.; Guruprasad P; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Kim KH; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Chun I; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Angelos MG; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Pajarillo R; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Hong SJ; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Lee YG; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Republic of Korea.; Shestova O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Shaw C; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Cohen I; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Gupta A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Vu T; viTToria Biotherapeutics, Philadelphia, PA, USA.; Qian D; viTToria Biotherapeutics, Philadelphia, PA, USA.; Yang S; viTToria Biotherapeutics, Philadelphia, PA, USA.; Nimmagadda A; viTToria Biotherapeutics, Philadelphia, PA, USA.; Snook AE; viTToria Biotherapeutics, Philadelphia, PA, USA.; Siciliano N; viTToria Biotherapeutics, Philadelphia, PA, USA.; Rotolo A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Inamdar A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA.; Harris J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA.; Ugwuanyi O; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Wang M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Carturan A; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Paruzzo L; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Chen L; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Ballard HJ; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Blanchard T; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Xu C; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Abdel-Mohsen M; Vaccine and Immunotherapy Center, Wistar Institute, Philadelphia, PA, USA.; Gabunia K; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Wysocka M; Department of Dermatology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA.; Linette GP; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Carreno B; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Barrett DM; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Oncology, Children's Hospital of Philadelphia, PA, USA.; Teachey DT; Division of Oncology, Children's Hospital of Philadelphia, PA, USA.; Posey AD; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Powell DJ Jr; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA.; Sauter CT; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Pileri S; Division of Haematopathology, Istituto Europeo di Oncologia IRCCS, Italy.; Pillai V; Division of Hemato-pathology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Scholler J; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Rook AH; Department of Dermatology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA, USA.; Schuster SJ; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Barta SK; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Porazzi P; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Ruella M; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology and Oncology, Hospital of University of Pennsylvania, Philadelphia, PA, USA.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101688624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9468 (Electronic) Linking ISSN: 24709468 NLM ISO Abbreviation: Sci Immunol Subsets: MEDLINE

Blanchard, T.; Posey, A.D.; Faridi, P.; Huang, G.; Lim, T.C.C.; Ayala, R.; Purcell, A.W.; Xu, C.; Gabunia, K.; Ji, M.; Scholler, J.; Linette, G.P.; June, C.H.; Carreno, B.M.; Bear, A.S.; Rasool, R.U.; Asangani, I.A.

In: Scientific Reports. (Scientific Reports, December 2025, 15(1))

Chesneau, O.; Min, M.; Herbst, T.; Waters, L. B. F. M.; Hillier, D. J.; Leinert, Ch.; De Koter, A.; Pascucci, I.; Jaffe, W.; Kohler, R.; Alvarez, C.; Van Boekel, R.; Brandner, W.; Graser, U.; Lagrange, A. M.; Lenzen, R.; Morel, S.; Scholler, M.

Golinelli, G.; Scholler, J.; Song, D.; Gabunia, K.; Fan, T.; Berjis, A.; Sheppard, N.; Alessandrini, M.; Roussel-Gervais, A.; Šakić, A.; Kili, S.; June, C.; Levine, B.L.

Cytotherapy. 25(6):S225-S225

Jørgensen, H. L.; Schøller, J.; Sand, J. C.; Bjuring, M.; Hassager, C.; Christiansen, C.

BMJ: British Medical Journal, 1996 Sep 01. 313(7057), 586-590.

Scholler J; Song A; Deshmukh M; Song D; June CH; Siegel DL

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Gerson J; University of Vermont Medical Center, Burlington.; Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Cook M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Frey NV; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Shea J; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Cervini A; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Marshall A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Four M; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Davis MM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Jadlowsky JK; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Chew A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Pequignot E; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Gonzalez V; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Noll JH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Rojas-Levine J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Plesa G; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Scholler J; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Siegel DL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Porter DL; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Ghassemi S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Rech A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Leskowitz RM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Fraietta JA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia.; Hwang WT; Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia.; Hexner E; Cell Therapy and Transplant Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.; June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Gohil, M.; Xu, J.; McKee, J.S.; Rojas Levine, J.; Hasenmayer, D.; Eby, P.; Dai, A.; Mackey, S.; Jain, A.; Haines, K.M.; Koterba, N.; Kulikovskaya, I.; Gupta, M.; Chen, F.; Gonzalez, V.E.; Gabunia, K.; Scholler, J.; Young, R.; Siegel, D.; Levine, B.L.; Chew, A.; June, C.; Leskowitz, R.M.; Lacey, S.; Plesa, G.; Davis, M.M.

Cytotherapy. 23(5):S160-S160